Eupalinolide J Inhibits Cancer Metastasis by Promoting STAT3 Ubiquitin-Dependent Degradation

Area of Science:

• Natural Products Chemistry
• Molecular Biology
• Cancer Research

Background:

• Eupalinolide J (EJ), derived from Eupatorium lindleyanum (EL), exhibits antitumor properties.
• STAT3 and Akt signaling pathways are implicated in cancer progression.

Purpose of the Study:

• To identify Eupalinolide J (EJ) as a potential anti-cancer metastatic agent.
• To elucidate the mechanism by which EJ inhibits cancer cell metastasis.

Main Methods:

• Target prediction and molecular docking techniques were employed for initial screening.
• In vitro and in vivo experiments assessed EJ's effect on cancer metastasis.
• Molecular biology techniques, including STAT3 knockdown and protein expression analysis, were utilized.

Main Results:

• EJ demonstrated significant inhibition of cancer cell metastasis both in vitro and in vivo.
• EJ reduced the expression of STAT3, MMP-2, and MMP-9 proteins.
• EJ was found to promote STAT3 ubiquitin-dependent degradation, leading to the downregulation of MMP-2 and MMP-9.

Conclusions:

• Eupalinolide J acts as a STAT3 degradation agent, effectively inhibiting cancer cell metastasis.
• EJ's mechanism involves downregulating metastasis-related genes MMP-2 and MMP-9 via STAT3 degradation.
• EJ is a promising candidate for future cancer therapy applications.